CT1

Welcome to the Brand page for “CT1”, which is offered here for Anti-inflammatory pharmaceutical products for the treatment of asthma;critical therapeutics one;.

Its status is currently believed to be active. Its class is unavailable. “CT1” is believed to be currently owned by “Critical Therapeutics, Inc.”

Owner:
CRITICAL THERAPEUTICS, INC.
Owner Details
Description:
Anti-inflammatory pharmaceutical products for the treatment of asthma;CRITICAL THERAPEUTICS ONE;
Categories: ANTI INFLAMMATORY PHARMACEUTICAL PRODUCTS